UKRI translation: MRC proof of concept: stage two

Résumé

This Medical Research Council (MRC) funding call supports the development and testing of novel therapeutics, medical devices, diagnostics, and other interventions through proof of concept stage two funding. Applicants must be employed at a research organisation eligible for MRC funding. The application deadline is 4 November 2026.

This MRC call focuses on medical research and development of therapeutics, medical devices, and diagnostics—sectors not aligned with Acme Corporation's core competencies in semiconductors and AI. While the call is UK-based (within target regions), it explicitly requires employment at research organisations and is fundamentally mismatched with the client's industrial innovation and deep-tech priorities in semiconductor and AI domains.

Scores détaillés

Pas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.

Description

This funding opportunity was previously titled ‘Developmental pathway funding scheme: stage one’. Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions. You must be employed at a research organisation eligible for MRC funding.